Literature DB >> 11259773

Characterization of melanin concentrating hormone and preproorexin expression in the murine hypothalamus.

N A Tritos1, J W Mastaitis, E Kokkotou, E Maratos-Flier.   

Abstract

Melanin concentrating hormone (MCH) and the orexins (A and B) have been identified as neuropeptides localized to the lateral hypothalamic area (LHA) and are potential regulators of energy homeostasis. Potential factors regulating expression of both MCH and the orexins include fasting and leptin. Previous studies have generated conflicting data and, as there is little leptin receptor expressed in the lateral hypothalamus, it is likely that any observed leptin effects on these peptides are indirect. In this study, we examined MCH and preproorexin expression in mice in physiological states of starvation, with or without leptin administration, in addition to characterizing MCH and preproorexin expression in well-known obesity models, including ob/ob and UCP-DTA mice. Neuropeptide Y (NPY) expression in the arcuate nucleus was used as a positive control. After a 60-h fast, expression of both NPY and MCH mRNA was increased (by 148 and 33%, respectively) while preproorexin expression in the murine LHA did not change. Leptin administration to fasted mice blunted the rise in MCH and NPY expression towards control levels. In contrast, there was a 78% increase in preproorexin expression in fasted mice in response to peripheral leptin administration. MCH expression was increased (by 116%) in ob/ob mice at baseline, as we have previously reported. In addition, leptin treatment of ob/ob mice blunted the increase in MCH expression. In contrast, preproorexin expression did not differ in the leptin-deficient ob/ob mice or in the obese hyperleptinemic brown adipose tissue deficient (UCP-DTA) mice in comparison with controls. In summary, MCH expression is increased in two states of decreased leptin, fasting and ob/ob mice, and leptin replacement blunts MCH expression in both paradigms. Thus, MCH expression appears to be regulated by leptin. In contrast, preproorexin expression does not respond acutely to fasting, although it is acutely increased by leptin treatment during fasting. These preproorexin responses are in contrast to those seen with well-characterized orexigenic neuropeptides, such as NPY and AgRP, suggesting that appetite regulation may not be a significant physiological role of orexins. This conclusion is further supported by the observation that orexin ablated mice have arousal and not feeding deficits.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11259773     DOI: 10.1016/s0006-8993(01)02066-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

Review 1.  Appetite and energy balance signals from adipocytes.

Authors:  Paul Trayhurn; Chen Bing
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 2.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 3.  Neuronal control of energy homeostasis.

Authors:  Qian Gao; Tamas L Horvath
Journal:  FEBS Lett       Date:  2007-12-03       Impact factor: 4.124

4.  Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.

Authors:  Teruhiko Shimokawa; Monica V Kumar; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

5.  Oestradiol decreases melanin-concentrating hormone (MCH) and MCH receptor expression in the hypothalamus of female rats.

Authors:  J Santollo; L A Eckel
Journal:  J Neuroendocrinol       Date:  2013-06       Impact factor: 3.627

6.  Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons.

Authors:  Gwendolyn W Louis; Gina M Leinninger; Christopher J Rhodes; Martin G Myers
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 7.  New aspects of melanocortin signaling: a role for PRCP in α-MSH degradation.

Authors:  Sabrina Diano
Journal:  Front Neuroendocrinol       Date:  2010-10-25       Impact factor: 8.606

8.  Neurochemical characterization of neurons expressing melanin-concentrating hormone receptor 1 in the mouse hypothalamus.

Authors:  Melissa J S Chee; Pavlos Pissios; Eleftheria Maratos-Flier
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

9.  Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype.

Authors:  Gabriella Segal-Lieberman; Richard L Bradley; Efi Kokkotou; Michael Carlson; Daniel J Trombly; Xiaomei Wang; Sarah Bates; Martin G Myers; Jeffrey S Flier; Eleftheria Maratos-Flier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-01       Impact factor: 11.205

10.  Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice.

Authors:  A Gomori; A Ishihara; M Ito; H Matsushita; M Ito; S Mashiko; H Iwaasa; M Matsuda; M A Bednarek; S Qian; D J Macneil; A Kanatani
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.